A patient with worsening chronic kidney disease presents with elevated serum creatinine and BUN levels, hyperkalemia, fluid overload, and anemia. The nurse is reviewing the current interventions, which include IV furosemide administration, potassium-binding resin, and supplemental oxygen. Which nursing assessment is most critical to perform next to evaluate the effectiveness of the treatment plan?

A) Monitor the patient's urine output and assess for changes in edema.

B) Check the patient's blood pressure to assess for hypotension.

C) Measure the patient's blood glucose levels to monitor for hyperglycemia.

D) Evaluate the patient's pain levels to ensure comfort.

A patient with chronic kidney disease presents with elevated serum creatinine, BUN, and hyperkalemia, along with decreased urine output and signs of fluid overload. Which nursing intervention is most critical to address first?

B) Administer furosemide intravenously to reduce fluid overload.

A) Administer supplemental oxygen to improve oxygen saturation.

B) Administer furosemide intravenously to reduce fluid overload.

C) Provide a potassium-binding resin to address hyperkalemia.

D) Monitor cardiac status continuously for arrhythmias.

A patient with chronic kidney disease is being treated for persistent hyperkalemia and anemia. Which of the following nursing interventions should be prioritized to address the potential risk of cardiac complications in this patient?

A) Administering erythropoiesis-stimulating agents

C) Adjusting antihypertensive medications

D) Providing dietary education on low-potassium foods

A patient with chronic kidney disease is experiencing persistent hyperkalemia despite treatment. Which nursing intervention is most appropriate to address the risk of hyperkalemia-induced arrhythmias in this patient?

B) Administer prescribed potassium-binding resin as per the physician's orders.

A) Encourage an increased intake of potassium-rich foods to improve overall nutrition.

B) Administer prescribed potassium-binding resin as per the physician's orders.

C) Discontinue furosemide to prevent further electrolyte imbalances.

D) Increase fluid intake to promote renal excretion of potassium.

A patient with renal impairment presents with a creatinine level of 3.2 mg/dL, BUN of 48 mg/dL, and serum bicarbonate level of 17 mEq/L. The nurse is preparing to educate the patient on dietary modifications to manage metabolic acidosis. Which dietary recommendation should the nurse prioritize to address the patient's condition?

B) Reduce protein intake to decrease acid load.

A) Increase intake of citrus fruits to boost vitamin C levels.

B) Reduce protein intake to decrease acid load.

C) Encourage high potassium foods to support electrolyte balance.

D) Increase dairy consumption to enhance calcium levels.

A patient with chronic kidney disease presents with a creatinine level of 3.2 mg/dL, BUN of 48 mg/dL, and serum bicarbonate level of 17 mEq/L. The nurse recognizes the need to address the metabolic acidosis. Which of the following interventions is most appropriate to help manage the patient’s acid-base imbalance?

C) Administer sodium bicarbonate as prescribed to correct acidosis

A) Administer a calcium supplement to bind phosphate

B) Initiate a high-protein diet to promote healing

C) Administer sodium bicarbonate as prescribed to correct acidosis

D) Encourage increased fluid intake to promote renal perfusion

A patient with renal impairment presents with increased fatigue, mild dyspnea on exertion, and laboratory findings indicating metabolic acidosis and hyperkalemia. What is the priority nursing intervention to prevent cardiac complications in this patient?

C) Prepare to administer sodium polystyrene sulfonate to lower potassium levels.

A) Administer a loop diuretic to reduce fluid overload.

B) Initiate a low-potassium diet to manage hyperkalemia.

C) Prepare to administer sodium polystyrene sulfonate to lower potassium levels.

D) Monitor the patient's oxygen saturation continuously.

A patient with renal impairment presents with increased fatigue, mild dyspnea, and laboratory results consistent with metabolic acidosis and hyperkalemia. Which nursing intervention should be prioritized to address the patient's current condition?

C) Initiate continuous cardiac monitoring due to elevated potassium levels.

A) Administer sodium bicarbonate to correct metabolic acidosis.

B) Restrict fluid intake to manage potential fluid overload.

C) Initiate continuous cardiac monitoring due to elevated potassium levels.

D) Encourage deep breathing exercises to improve respiratory status.

A patient with fluid overload is being treated with a loop diuretic and now shows signs of pulmonary edema and hyperkalemia. Which nursing intervention is the priority to address the patient's current respiratory distress?

C) Apply supplemental oxygen and ensure adequate ventilation

A) Increase the rate of diuretic administration to reduce fluid overload

B) Administer the ordered potassium-binding resin to lower serum potassium levels

C) Apply supplemental oxygen and ensure adequate ventilation

D) Prepare the patient for immediate hemodialysis to address renal dysfunction

A patient with fluid overload presents with worsening respiratory distress and elevated serum potassium levels despite dietary modifications. After the initiation of a loop diuretic and supplemental oxygen, which of the following nursing interventions is the highest priority to address the underlying issues?

B) Administer the prescribed insulin and glucose infusion to lower serum potassium levels.

A) Increase the rate of supplemental oxygen to improve oxygen saturation.

B) Administer the prescribed insulin and glucose infusion to lower serum potassium levels.

C) Position the patient in a high Fowler's position to facilitate lung expansion.

D) Prepare the patient for immediate dialysis to address renal dysfunction.

kidney failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced renal blood flow leads to decreased glomerular filtration rate (GFR), impairing the kidneys' ability to filter waste, balance electrolytes, and maintain fluid homeostasis, often stemming from conditions like hypertension or diabetes.

• Secondary mechanism: Damage to nephron structures, such as glomeruli or tubules, can result from prolonged inflammation or toxic injury, further diminishing renal function and causing accumulation of waste products like urea and creatinine in the blood.

• Key complication: Fluid overload and electrolyte imbalances, such as hyperkalemia, can occur due to impaired excretion, posing risks of cardiac arrhythmias and other systemic effects, necessitating careful monitoring and intervention in clinical practice.

Patient Profile

Demographics:

52-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Stage 3 Chronic Kidney Disease

• Current medications: Lisinopril, Metformin, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in legs

• Key symptoms: Shortness of breath, decreased urine output, persistent nausea

• Vital signs: Blood Pressure 155/95 mmHg, Heart Rate 92 bpm, Respiratory Rate 20 breaths per minute, Temperature 37.2°C, Oxygen Saturation 93% on room air

Section 1

As the medical team continues to assess the patient's condition, new diagnostic results reveal a concerning elevation in serum creatinine and blood urea nitrogen (BUN) levels, indicating worsening renal function. The patient's creatinine level has risen to 3.2 mg/dL from a previous 2.5 mg/dL, and BUN is now at 48 mg/dL. These findings, combined with the decreased urine output of less than 400 mL in the past 24 hours, suggest an acute worsening of his chronic kidney disease. Additionally, laboratory results show hyperkalemia with serum potassium at 5.9 mEq/L, heightening the risk of cardiac complications. His hemoglobin level has also decreased to 9.8 g/dL, indicative of anemia, which may be contributing to his fatigue.

Clinically, the patient's physical examination reveals pitting edema in both legs extending to the knees and bibasilar crackles on auscultation, suggesting fluid overload. The patient's oxygen saturation has decreased to 91% on room air, and he experiences mild dyspnea at rest. These signs highlight the need for immediate intervention to manage the fluid overload and prevent further respiratory compromise. The medical team is faced with the challenge of addressing the electrolyte imbalances and anemia while considering the patient's underlying hypertension and diabetes, which complicate the management strategy.

In response to these findings, the healthcare team initiates a plan to stabilize the patient's condition. Furosemide is administered intravenously to promote diuresis and reduce fluid overload, while a potassium-binding resin is considered to manage hyperkalemia. The patient is also started on supplemental oxygen to improve his oxygen saturation. The team must continually evaluate the effectiveness of these interventions and monitor the patient's cardiac status closely due to the risk of arrhythmias. As the patient's journey unfolds, the focus will be on adjusting his medication regimen to optimize renal function, manage blood pressure, and control blood glucose levels, all critical to preventing further deterioration and complications.

Section 2

Following the initial interventions, the medical team observes the patient's response closely. Over the next 24 hours, there is a moderate improvement in urine output, which increases to 600 mL, indicating a partial response to the administered furosemide. However, the patient's electrolyte imbalances persist, with serum potassium levels only slightly decreasing to 5.5 mEq/L, necessitating continued use of the potassium-binding resin to minimize the risk of hyperkalemia-induced arrhythmias. The patient's dyspnea shows slight improvement with supplemental oxygen, and his oxygen saturation stabilizes at 94%. Despite these positive changes, the patient continues to experience fatigue, which is likely compounded by persistent anemia and underlying chronic conditions.

A repeat set of laboratory tests reveals that the patient's hemoglobin level has further declined to 9.4 g/dL, suggesting ongoing or worsening anemia. The medical team considers erythropoiesis-stimulating agents to address the anemia while evaluating the potential need for an iron supplement, given the patient's chronic kidney disease and its impact on erythropoietin production. Additionally, the patient's blood pressure remains challenging to control, with readings fluctuating around 150/90 mmHg, prompting adjustments in his antihypertensive regimen. The team discusses the importance of optimizing blood pressure control to prevent further renal damage and cardiovascular complications.

As the medical team continues to monitor the patient's condition, they remain vigilant for any signs of new complications, particularly related to his cardiac status and fluid balance. Regular ECG monitoring is initiated to detect any potential arrhythmias early, given the persistent risk posed by hyperkalemia. The team also emphasizes the need for continuous education on lifestyle modifications, dietary restrictions, and medication adherence to empower the patient in managing his chronic conditions effectively. The focus remains on stabilizing the patient's current condition while preventing further deterioration, underscoring the critical role of comprehensive and dynamic care management.

Section 3

As the medical team continues to monitor the patient, a new set of diagnostic results provides further insight into his condition. The patient's repeat kidney function tests reveal a creatinine level of 3.2 mg/dL, which is a slight improvement from the initial presentation but still indicates significant renal impairment. The blood urea nitrogen (BUN) level remains elevated at 48 mg/dL, necessitating ongoing assessment of renal function and potential progression towards chronic kidney disease. Importantly, the patient's serum bicarbonate level has decreased to 17 mEq/L, suggesting metabolic acidosis, a common complication in renal failure that requires prompt attention to prevent exacerbation of his overall condition.

These findings prompt the medical team to reassess the current management plan, particularly focusing on addressing the metabolic acidosis. Sodium bicarbonate therapy is considered to help correct the acid-base imbalance, and dietary adjustments are recommended to minimize the intake of protein and other acid-producing nutrients. The patient's nutritional status is also evaluated, as his albumin level has decreased to 3.2 g/dL, indicating potential malnutrition and the need for dietary interventions to support overall health and recovery.

The medical team discusses the implications of these new diagnostic results with the patient, emphasizing the importance of adhering to the prescribed treatment regimen and lifestyle modifications. Education on the signs and symptoms of worsening acidosis, such as increased fatigue, confusion, or dyspnea, is provided to ensure timely reporting and management. As they continue to navigate the complexities of his care, the team remains focused on stabilizing metabolic parameters and preventing further renal deterioration, while preparing for potential adjustments in treatment should his condition change.

Section 4

As the medical team closely monitors the patient's ongoing treatment, they notice a change in his clinical status that prompts further investigation. The patient, who had previously been stable, now reports increased fatigue and mild dyspnea on exertion. His vital signs reveal a blood pressure of 138/86 mmHg, heart rate of 92 beats per minute, respiratory rate of 22 breaths per minute, and an oxygen saturation of 94% on room air. These subtle changes raise concerns about potential fluid overload and the impact of metabolic acidosis on his respiratory system.

In response to these symptoms, repeat laboratory tests are conducted. The results show a slight increase in serum creatinine to 3.4 mg/dL, suggesting possible progression of renal impairment. The blood urea nitrogen (BUN) level has also risen to 52 mg/dL, further indicating ongoing renal dysfunction. Notably, the serum bicarbonate level remains low at 16 mEq/L, confirming persistent metabolic acidosis. Additionally, the patient's potassium level is noted to be elevated at 5.8 mEq/L, raising the risk of cardiac complications and necessitating immediate intervention.

The team discusses the need for adjustments in the management plan, focusing on correcting electrolyte imbalances and optimizing fluid status. A diuretic may be considered to address potential fluid retention, and dietary modifications are reinforced to control potassium intake. The patient's response to sodium bicarbonate therapy is closely evaluated, and his oxygenation status is monitored to prevent respiratory compromise. By addressing these interconnected issues, the medical team aims to stabilize the patient's condition and prevent further complications, while preparing for the next step in his ongoing care journey.

Section 5

As the medical team implements the revised management plan, they notice a change in the patient’s status that demands immediate attention. Despite the initiation of a loop diuretic to manage fluid overload, the patient now exhibits signs of worsening respiratory distress. His respiratory rate has increased to 28 breaths per minute, and his oxygen saturation has dropped further to 90% on room air, prompting the application of supplemental oxygen. Auscultation reveals new bilateral crackles at the lung bases, suggestive of pulmonary congestion. These findings indicate that the fluid overload may have progressed to pulmonary edema, complicating the patient's clinical picture.

In response to these developments, a chest X-ray is ordered, which confirms the presence of bilateral infiltrates consistent with pulmonary edema. Concurrently, repeat laboratory tests indicate that the serum potassium level remains elevated at 5.9 mEq/L despite dietary modifications, underscoring the need for more aggressive measures to prevent cardiac complications. The team decides to initiate a low-dose infusion of insulin and glucose to facilitate intracellular potassium shift, along with a potassium-binding resin to enhance elimination.

The patient's response to these interventions is closely monitored. Over the next few hours, his respiratory status begins to stabilize with the supplemental oxygen, and his work of breathing decreases. The insulin and glucose infusion successfully lower the potassium level to 5.3 mEq/L, reducing the immediate risk of arrhythmias. Despite these improvements, the team remains vigilant, understanding that the underlying renal dysfunction and metabolic acidosis require ongoing attention. Plans for a possible transition to renal replacement therapy are discussed, setting the stage for further adjustments in the patient's care trajectory.